Flavalta (epinephrine bitartrate, lidocaine hydrochloride)
New formulation or manufacturer
- Region
- 🇺🇸 US
- Active substance
- epinephrine bitartrate, lidocaine hydrochloride
- Company
- Deproco
- Status
- Approved
- FDA approval
- Thu 19 Mar 2026
- Designations
- New formulation or manufacturer
- Application
- NDA216564
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Thu 19 Mar 2026🇺🇸 FDA approval
FDA approves Flavalta (epinephrine bitartrate, lidocaine hydrochloride): new formulation or manufacturer
Deproco; NDA216564; New formulation or manufacturer; solution · source
Follow Flavalta
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.